Indivior Pharmaceuticals, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingNewest
None
No S-3 or F-3 shelf on file in the last 30 months.
None
No at-the-market programme on file in the last 30 months.
Warrants
The 10-Q filed 2026-08-03 is not read yet.
Cash
22.2 quarters
$222.0M on 2026-06-30 ÷ $10.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗
Raised: 1 of its filings are not read yet.
Also on file: $50.0M convertible notes, 2026-03-17 8-K ↗ · $650.0M term loan, 2026-08-01 8-K ↗